BioCentury | Oct 26, 2018
Emerging Company Profile

Karius: Blood will tell

...Blauwkamp and Stephen Quake University collaborators: Stanford, UCSF, Duke, Lurie Children’s, Rady Children’s, St. Jude, Florida Hospital Orlando...
BioCentury | Jun 5, 2014
Strategy

Sanford-Burnham goes fourth

Sanford-Burnham Medical Research Institute 's outreach to industry has resulted historically in deals focused either on a narrow range of projects or the work of individual investigators, but the institute also has been seeking broader...
BioCentury | Feb 13, 2014
Strategy

A gift for research

An anonymous $275 million gift propels the Sanford-Burnham Medical Research Institute more than halfway toward its funding goal for a newly announced 10-year drug development plan that involves speeding the development of preclinical therapies that...
BioCentury | Nov 11, 2013
Strategy

New York translation

Now headquartered at the newly opened Translational Clinical Research Center in New York, Roche 's Pharma Research & Early Development organization has undergone another retooling intended to increase its efficiency and productivity. The center will...
BioCentury | Aug 29, 2013
Strategy

Collaborating against diabetes complications

Pfizer Inc. 's diabetes deal with the Sanford-Burnham Medical Research Institute could help reverse a trend that has seen the pharma arriving late-or not at all-to the party with new targets for the indication. Indeed,...
BioCentury | Feb 18, 2013
Company News

Takeda, Florida Hospital, Sanford-Burnham Medical Research Institute deal

Takeda, the Florida Hospital healthcare system and the institute extended by two years a 2010 deal to discover and develop therapies to treat obesity. The initial two-year deal covered identification of targets and biomarkers. Under...
BioCentury | Mar 1, 2012
Strategy

Personalized medicine triumvirate

Three Florida-based institutions are pooling resources in the Personalized Medicine Partnership of Florida, which is tasked with discovering markers that could predict individual responses to drugs for cancer, metabolic diseases and cardiovascular diseases. PMP Florida...
BioCentury | Feb 13, 2012
Company News

Florida Hospital, H. Lee Moffitt Cancer Center, Sanford-Burnham Medical Research Institute cancer, endocrine/metabolic, cardiovascular news

The institutes partnered with the hospital to launch the Personalized Medicine Partnership of Florida to discover and develop therapies for cancer and metabolic diseases, including obesity, diabetes and cardiovascular diseases. Researchers at the institutions will...
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

Since the economic downturn of 2008, doom has become ingrained in the biopharma narrative. According to the mantra, budgets for great science have flatlined. New startups can't find VC money to translate great science because...
BioCentury | Apr 21, 2011
Strategy

A two-way street in metabolic disease

A two-way flow of information between lab and clinic has enabled research collaborators at the Sanford-Burnham Medical Research Institute and The Translational Research Institute for Metabolism and Diabetes to identify markers that reflect subsets of...
Items per page:
1 - 10 of 12
BioCentury | Oct 26, 2018
Emerging Company Profile

Karius: Blood will tell

...Blauwkamp and Stephen Quake University collaborators: Stanford, UCSF, Duke, Lurie Children’s, Rady Children’s, St. Jude, Florida Hospital Orlando...
BioCentury | Jun 5, 2014
Strategy

Sanford-Burnham goes fourth

Sanford-Burnham Medical Research Institute 's outreach to industry has resulted historically in deals focused either on a narrow range of projects or the work of individual investigators, but the institute also has been seeking broader...
BioCentury | Feb 13, 2014
Strategy

A gift for research

An anonymous $275 million gift propels the Sanford-Burnham Medical Research Institute more than halfway toward its funding goal for a newly announced 10-year drug development plan that involves speeding the development of preclinical therapies that...
BioCentury | Nov 11, 2013
Strategy

New York translation

Now headquartered at the newly opened Translational Clinical Research Center in New York, Roche 's Pharma Research & Early Development organization has undergone another retooling intended to increase its efficiency and productivity. The center will...
BioCentury | Aug 29, 2013
Strategy

Collaborating against diabetes complications

Pfizer Inc. 's diabetes deal with the Sanford-Burnham Medical Research Institute could help reverse a trend that has seen the pharma arriving late-or not at all-to the party with new targets for the indication. Indeed,...
BioCentury | Feb 18, 2013
Company News

Takeda, Florida Hospital, Sanford-Burnham Medical Research Institute deal

Takeda, the Florida Hospital healthcare system and the institute extended by two years a 2010 deal to discover and develop therapies to treat obesity. The initial two-year deal covered identification of targets and biomarkers. Under...
BioCentury | Mar 1, 2012
Strategy

Personalized medicine triumvirate

Three Florida-based institutions are pooling resources in the Personalized Medicine Partnership of Florida, which is tasked with discovering markers that could predict individual responses to drugs for cancer, metabolic diseases and cardiovascular diseases. PMP Florida...
BioCentury | Feb 13, 2012
Company News

Florida Hospital, H. Lee Moffitt Cancer Center, Sanford-Burnham Medical Research Institute cancer, endocrine/metabolic, cardiovascular news

The institutes partnered with the hospital to launch the Personalized Medicine Partnership of Florida to discover and develop therapies for cancer and metabolic diseases, including obesity, diabetes and cardiovascular diseases. Researchers at the institutions will...
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

Since the economic downturn of 2008, doom has become ingrained in the biopharma narrative. According to the mantra, budgets for great science have flatlined. New startups can't find VC money to translate great science because...
BioCentury | Apr 21, 2011
Strategy

A two-way street in metabolic disease

A two-way flow of information between lab and clinic has enabled research collaborators at the Sanford-Burnham Medical Research Institute and The Translational Research Institute for Metabolism and Diabetes to identify markers that reflect subsets of...
Items per page:
1 - 10 of 12